Collaborate Disseminate
The biggest tragedy of pet ownership is that they just don’t live long enough. Thankfully scientists are working on that, with a new cancer vaccine for dogs that almost doubles their survival rates in the face of certain types of the disease.Continue R… Continue reading Cancer vaccine for dogs almost doubles survival rates in clinical trial
Omalizumab, currently used to treat asthma, has been shown to substantially reduce the risk of potentially life-threatening reactions in people aged one and older with multiple common food allergies, including peanuts, following accidental exposure. Wh… Continue reading Asthma drug staves off food allergies in up to 68% of patients
Scientists have made a synthetic antibody that can prevent paralysis and death inflicted by the venom of elapids, a large family of mostly deadly snakes found around the world. The discovery has us slithering ever closer to developing a single, univers… Continue reading Fangs a lot! Synthetic antibody could be key to universal antivenom
Researchers have found that getting a vaccine booster shot in a different arm from the one you got the first in may improve the body’s immune response up to four-fold. While they exclusively studied responses to the COVID-19 vaccine, they suspect this … Continue reading Getting vaccines in different arms improves effectiveness, study finds
Researchers have combined diagnostics and therapeutics, using radioactive monoclonal antibodies to find and destroy a particularly lethal form of pancreatic cancer. The one-two punch provided by the novel approach could pave the way for earlier detecti… Continue reading ‘Theranostics’ approach seeks and destroys deadly pancreatic cancer
Researchers have found that an intranasal immunotherapy drug, currently being tested as a treatment for multiple sclerosis, reduced brain inflammation and improved cognition in mice with Alzheimer’s disease, independent of the amount of beta-amyloid plaques present. They say the treatment could benefit people in the later stages of the disease.
Tags: Alzheimer’s Disease, Brain, Inflammatory, antibodies, Brigham and Women’s Hospital
Continue reading Nasal Alzheimer’s drug effective regardless of brain plaque levels
Researchers are expected to begin human clinical trials in early 2024 to test the safety and efficacy of vaccines to prevent heroin and fentanyl overdoses. While there is still a way to go, if approved, the vaccines could revolutionize the treatment of… Continue reading Vaccines to prevent fentanyl, heroin overdose close to human trials
Researchers have developed a human antibody that targets the opioid fentanyl and its derivatives, blocking the drug’s effects and reversing overdose better than currently available treatments. With clinical trials pending, the novel antibody therapy co… Continue reading Human antibody proves a potent treatment for opioid overdose
Metastatic cancer accounts for up to 90% of all cancer deaths in the US annually. But with researchers developing a first-of-its-kind drug that inhibits the process by which cancer cells spread around the body, it’s hoped that this number will soon go … Continue reading First-of-its-kind cancer drug targets mechanism that causes metastasis
Some sharks get a new set of teeth every few weeks, while crocodiles can go through thousands of chompers in their long lifetimes. Yet the ability to endlessly replace our pearly whites is something that’s eluded us and nearly all other mammals. By the… Continue reading Humans may soon grow new teeth, with promising drug trial set